You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

CLINICAL TRIALS PROFILE FOR CELEXA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for CELEXA

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00018902 ↗	Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)	Completed	National Institute of Mental Health (NIMH)	Phase 2/Phase 3	2001-01-01	The purpose of the study is to determine how best to treat adolescents with depression that is "resistant" to the first SSRI antidepressant they have tried. Participants receive one of three other antidepressant medications, either alone or in combination with cognitive behavioral therapy.
NCT00018902 ↗	Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)	Completed	University of Pittsburgh	Phase 2/Phase 3	2001-01-01	The purpose of the study is to determine how best to treat adolescents with depression that is "resistant" to the first SSRI antidepressant they have tried. Participants receive one of three other antidepressant medications, either alone or in combination with cognitive behavioral therapy.
NCT00044798 ↗	Magnetic Stimulation Therapy for Treating Vascular Depression	Completed	National Institute of Mental Health (NIMH)	Phase 3	2001-09-01	This 12-week study will evaluate the effectiveness of repetitive transcranial magnetic stimulation (rTMS) of the brain, followed by citalopram (Celexa®), for treatment of depression associated with small vascular lesions in the brain (vascular depression).
NCT00044798 ↗	Magnetic Stimulation Therapy for Treating Vascular Depression	Completed	University of Iowa	Phase 3	2001-09-01	This 12-week study will evaluate the effectiveness of repetitive transcranial magnetic stimulation (rTMS) of the brain, followed by citalopram (Celexa®), for treatment of depression associated with small vascular lesions in the brain (vascular depression).
NCT00047450 ↗	Antidepressant Treatment in Older Adults With Schizophrenia	Completed	National Institute of Mental Health (NIMH)	N/A	2001-09-01	The purpose of this study is to evaluate the safety and effectiveness of citalopram (Celexa) for the treatment of depressive symptoms in middle-aged and elderly patients with schizophrenia.
NCT00047450 ↗	Antidepressant Treatment in Older Adults With Schizophrenia	Completed	Veterans Medical Research Foundation	N/A	2001-09-01	The purpose of this study is to evaluate the safety and effectiveness of citalopram (Celexa) for the treatment of depressive symptoms in middle-aged and elderly patients with schizophrenia.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for CELEXA

Condition Name

Chart
Table

Condition Name for CELEXA
Intervention	Trials
Depression	11
Major Depressive Disorder	11
Healthy	4
Schizophrenia	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for CELEXA
Intervention	Trials
Depression	29
Depressive Disorder	24
Depressive Disorder, Major	15
Disease	12
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for CELEXA

Trials by Country

Map
Table

Trials by Country for CELEXA
Location	Trials
United States	106
Canada	6
India	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for CELEXA
Location	Trials
California	14
New York	13
Pennsylvania	9
Massachusetts	8
Ohio	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for CELEXA

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for CELEXA
Clinical Trial Phase	Trials
Phase 4	14
Phase 3	5
Phase 2/Phase 3	3
[disabled in preview]	27
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for CELEXA
Clinical Trial Phase	Trials
Completed	46
Withdrawn	3
Recruiting	2
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CELEXA

Sponsor Name

Chart
Table

Sponsor Name for CELEXA
Sponsor	Trials
National Institute of Mental Health (NIMH)	24
New York State Psychiatric Institute	7
University of Pittsburgh	5
[disabled in preview]	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for CELEXA
Sponsor	Trials
Other	52
NIH	33
Industry	7
[disabled in preview]	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.